{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:37:31Z","timestamp":1793263051714,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005329","name":"Guizhou Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.109700","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:27:04Z","timestamp":1792510024000},"page":"109700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["AI-guided identification of a covalent SMAD3 regulatory mechanism of celastrol in diabetic kidney disease"],"prefix":"10.1016","volume":"233","author":[{"given":"Pengchen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laihong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaodie","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0777-862X","authenticated-orcid":false,"given":"Xinwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2395-1692","authenticated-orcid":false,"given":"Ran","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.phrs.2026.109700_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","article-title":"Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function","volume":"17","author":"Brennan","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"11","key":"10.1016\/j.phrs.2026.109700_bib2","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41419-018-1157-x","article-title":"Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury","volume":"9","author":"Qi","year":"2018","journal-title":"Cell. Death Dis."},{"issue":"4","key":"10.1016\/j.phrs.2026.109700_bib3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.kint.2017.03.029","article-title":"Connective tissue growth factor regulates fibrosis-associated renal lymphangiogenesis","volume":"92","author":"Kinashi","year":"2017","journal-title":"Kidney Int."},{"issue":"3 Pt 2","key":"10.1016\/j.phrs.2026.109700_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/hy09t1.094234","article-title":"Angiotensin II and renal fibrosis","volume":"38","author":"Mezzano","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2026.109700_bib5","article-title":"Signaling Pathways Involved in Diabetic Renal Fibrosis","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2026.109700_bib6","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1681\/ASN.2020020190","article-title":"Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease","volume":"31","author":"Dwivedi","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7835","key":"10.1016\/j.phrs.2026.109700_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.phrs.2026.109700_bib8","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2026.109700_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216622","article-title":"Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells","volume":"587","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.phrs.2026.109700_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1728","article-title":"The type I TGF-beta receptor is covalently modified and regulated by sumoylation","volume":"10","author":"Kang","year":"2008","journal-title":"Nat. Cell. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2026.109700_bib11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural Products as Sources of New Drugs over the Nearly Four Decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.phrs.2026.109700_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00018-025-05688-8","article-title":"SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2","volume":"82","author":"Cai","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"31","key":"10.1016\/j.phrs.2026.109700_bib13","doi-asserted-by":"crossref","first-page":"23425","DOI":"10.1074\/jbc.C000345200","article-title":"Importin beta mediates nuclear translocation of Smad 3","volume":"275","author":"Xiao","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.109700_bib14","article-title":"The Active Compounds and Therapeutic Target of Tripterygium wilfordii Hook. f. in Attenuating Proteinuria in Diabetic Nephropathy: A Review","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"8","key":"10.1016\/j.phrs.2026.109700_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","article-title":"Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3","volume":"126","author":"Ye","year":"2020","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.phrs.2026.109700_bib16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/ard-2023-223859","article-title":"Tripterygium wilfordii derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosis","volume":"82","author":"Chitturi","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2026.109700_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.05.011","article-title":"Treatment of obesity with celastrol","volume":"161","author":"Liu","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.phrs.2026.109700_bib18","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/db18-1167","article-title":"Celastrol Reduces Obesity in MC4R Deficiency and Stimulates Sympathetic Nerve Activity Affecting Metabolic and Cardiovascular Functions","volume":"68","author":"Saito","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2026.109700_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156369","article-title":"Celastrol ameliorates fibrosis in Western diet\/tetrachloromethane-induced nonalcoholic steatohepatitis by suppressing Notch\/osteopontin signaling","volume":"137","author":"Li","year":"2025","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.phrs.2026.109700_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/iovs.64.3.9","article-title":"Celastrol Alleviates Corneal Stromal Fibrosis by Inhibiting TGF-beta1\/Smad2\/3-YAP\/TAZ Signaling After Descemet Stripping Endothelial Keratoplasty","volume":"64","author":"Liu","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.phrs.2026.109700_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101596","article-title":"Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP\/TAZ-TEAD Biosensors","volume":"11","author":"Nouri","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phrs.2026.109700_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2020.01.017","article-title":"Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity","volume":"320","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2026.109700_bib23","article-title":"Renoprotective mechanisms of celastrol in high glucose-mediated HK-2 cell injury through inhibition of the PI3K\/Akt\/NF-kappaB signalling pathway","volume":"41","author":"Wang","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.109700_bib24","first-page":"22","article-title":"Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect","volume":"9","author":"Luo","year":"2022","journal-title":"Mil. Med. Res."},{"issue":"4","key":"10.1016\/j.phrs.2026.109700_bib25","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.7150\/ijbs.101548","article-title":"Modulation of TGF-beta signaling new approaches toward kidney disease and fibrosis therapy","volume":"21","author":"Hong","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"38","key":"10.1016\/j.phrs.2026.109700_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo0987","article-title":"PKM2 promotes pulmonary fibrosis by stabilizing TGF-beta1 receptor I and enhancing TGF-beta1 signaling","volume":"8","author":"Gao","year":"2022","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.phrs.2026.109700_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biom16070932","article-title":"Overcoming the Druggability Hurdles of Celastrol: A Critical Review of Advanced Drug Delivery Strategies","volume":"16","author":"Xu","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2026.109700_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.558741","article-title":"Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.109700_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.130785","article-title":"Tributyltin chloride (TBTCL) induces cell injury via dysregulation of endoplasmic reticulum stress and autophagy in Leydig cells","volume":"448","author":"Chen","year":"2023","journal-title":"J. Hazard. Mater."},{"issue":"1","key":"10.1016\/j.phrs.2026.109700_bib30","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1038\/s41467-024-51321-w","article-title":"Data-driven quantum chemical property prediction leveraging 3D conformations with Uni-Mol","volume":"15","author":"Lu","year":"2024","journal-title":"Nat. Commun."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826016154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826016154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:21:28Z","timestamp":1793262088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826016154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"alternative-id":["S1043661826016154"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109700","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-guided identification of a covalent SMAD3 regulatory mechanism of celastrol in diabetic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.109700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109700"}}